Compounds > 3,3,5,5-tetramethyl-1-pyrroline n-oxide
Page last updated: 2024-09-04

3,3,5,5-tetramethyl-1-pyrroline n-oxide and dacarbazine

3,3,5,5-tetramethyl-1-pyrroline n-oxide has been researched along with dacarbazine in 1 studies

Compound Research Comparison

Studies
(3,3,5,5-tetramethyl-1-pyrroline n-oxide)		Trials
(3,3,5,5-tetramethyl-1-pyrroline n-oxide)		Recent Studies (post-2010)
(3,3,5,5-tetramethyl-1-pyrroline n-oxide)		Studies
(dacarbazine)		Trials
(dacarbazine)		Recent Studies (post-2010) (dacarbazine)
21067,5561,4633,429

Protein Interaction Comparison

ProteinTaxonomy3,3,5,5-tetramethyl-1-pyrroline n-oxide (IC50)dacarbazine (IC50)
Matrix metalloproteinase-9Homo sapiens (human)0.556

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gadjeva, V; Lazarova, G; Zheleva, A1

Other Studies

1 other study(ies) available for 3,3,5,5-tetramethyl-1-pyrroline n-oxide and dacarbazine

ArticleYear
Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
    Toxicology letters, 2003, Oct-15, Volume: 144, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antioxidants; Cyclic N-Oxides; Dacarbazine; Dose-Response Relationship, Drug; Drug Interactions; Escherichia coli; Free Radicals; Lomustine; Oxygen; Spin Labels; Staphylococcus aureus; Vitamin E

2003